High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

June 1, 2003

J. Sanford Schwartz, MD, Y. Richard Wang, MD, PhD, John G. F. Cleland, MD, Longlong Gao, MS, Mark Weiner, MD, Philip A. Poole-Wilson, MD, fo

The American Journal of Managed Care, June 2003, Volume 9, Issue 6